RecruitingNCT03642795

Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology)

Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology): Specific Tool for Evaluation of Observance of Rheumatology Treatment


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

150 participants

Start Date

Jun 23, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to develop a French language version of the Compliance-Questionnaire-Rheumatology for use in French and Francophone rheumatology services


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is validating a French-language version of the Compliance Questionnaire Rheumatology (CQR), a tool that measures how well patients follow their prescribed treatment regimen. The goal is to ensure this widely-used questionnaire works accurately for French-speaking patients with rheumatoid arthritis. Adults aged 18 and older with rheumatoid arthritis who have been taking methotrexate orally or by injection for at least 3 months at a stable dose may be eligible. Participation involves completing the questionnaire at two study visits and does not involve any change to your current treatment. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

Patients are asked to complete several questionnaires


Locations(4)

CHU Bordeaux

Bordeaux, France

CHRU Montpellier

Montpellier, France

CHU Nimes

Nîmes, France

CHU Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03642795


Related Trials